Entered agreement to acquire a portfolio of brands with revenue of $200 million and EBITDA of $95 million Breathe Right is an iconic and category‑leading brand with strong margins and cash flow generation...
Prestige Consumer Healthcare: Fiscal Q3 Earnings Snapshot
Revenue of $283.4 million in Q3, ahead of outlook Diluted EPS of $0.97 in Q3 and Adjusted Diluted EPS of $1.14, versus prior year Q3 Diluted EPS of $1.22 Repurchased approximately 0.8 million shares...
TARRYTOWN, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced it will issue its fiscal 2026 third quarter earnings...
Prestige Consumer Healthcare: Fiscal Q2 Earnings Snapshot
Revenue of $274.1 million in Q2, ahead of outlook Diluted EPS of $0.86 in Q2 and Adjusted Diluted EPS of $1.07, versus prior year Q2 Diluted EPS of $1.09 Repurchased approximately 1.1 million shares...
TARRYTOWN, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 second quarter and first half earnings release on Thursday,...
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global Consumer Staples Conference on Thursday, September...
Prestige Consumer Healthcare: Fiscal Q1 Earnings Snapshot
Revenue of $249.5 million in Q1; decline driven by limited eye care supply Diluted EPS of $0.95 in Q1, up approximately 6% versus prior year Adjusted Diluted EPS of $0.90 Announces agreement to acquire...